Telix Pharmaceuticals and United Imaging Healthcare Partner to Integrate Radiopharmaceuticals with PET Imaging Systems
Telix Pharmaceuticals and United Imaging Healthcare announced a strategic partnership on Tuesday to integrate their respective technologies in the field of theranostics. The collaboration aims to combine Telix’s portfolio of molecularly targeted radiation products with United Imaging’s advanced diagnostic imaging hardware to improve the accessibility and precision of cancer treatment.
The agreement establishes a framework for the two companies to conduct joint research and development, focusing on the deployment of diagnostic and therapeutic radiopharmaceuticals. Under the terms of the partnership, the companies will work to streamline the integration of Telix’s imaging agents with United Imaging’s PET/CT and PET/MR scanners. This initiative seeks to standardize imaging protocols for clinical trials and routine patient care, potentially reducing technical barriers for hospitals adopting theranostic workflows. Both organizations intend to leverage their global distribution networks to support the implementation of these integrated solutions across clinical sites.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 2, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]







